Globe Newswire
Globe Newswire
More Globe Newswire
View Older Stories View Newer Stories-
BridgeBio Pharma and Bayer Announce European Licensing Agreement for Acoramidis in ATTR-CM
-
Form 8.5 (EPT/RI) - Abrdn European Logistics Income Plc
-
Vistin Pharma ASA (VISTN) acquires minority share in CF Pharma (Hungary)
-
BNP Paribas launches a share buyback programme of EUR 1.055 billion
-
Cornish Metals to Bring Forward Refurbishment of New Cook’s Kitchen Shaft
-
Galantas Gold Announces Sampling Program for Gairloch Gold-Bearing VMS Project in Scotland, in Collaboration With University of Edinburgh
-
VAALCO Schedules Fourth Quarter and Full Year 2023 Earnings Release and Conference Call
-
Caledonia Mining Corporation Plc Trading update for the year ended December 31, 2023
-
Andrew Fisher Joins Verona Pharma as General Counsel
-
Medigene AG Expands Patent Portfolio in Japan for iM-TCR Technology to Directly Control TCR-T Safety and Efficacy, In Vivo
-
ING to repurchase shares for employee compensation
-
Subsea 7 share repurchases
-
Dividend payment ex-date of Arco Vara AS
-
South Korea has granted Lleida.net its sixth patent in the country
-
BioVie Inc. Announces Pricing of Public Offering
-
Transaction in Own Shares
-
BGHL (EUR): NAV(s)
-
BGHL (EUR): NAV(s)
-
BGHL (GBP): NAV(s)
-
BW Offshore: Ex dividend USD 0.088 today
-
-
-
Novartis presents new data on safety and efficacy of Zolgensma, including maintained and improved motor milestones in older and heavier children with SMA
-
Novartis presents new data on safety and efficacy of Zolgensma, including maintained and improved motor milestones in older and heavier children with SMA
-
Virtualware appoints a new USA operations president, John A. Cunningham, to lead the company's growth in the American market
-
Coherus Completes Divestiture of Ophthalmology Franchise
-
Start of Day Message
-
Sandoz acquires CIMERLI® business from Coherus, further building biosimilar and ophthalmology leadership in US market
-
Vivoryon Therapeutics N.V. Provides Update on VIVIAD Phase 2b Study of Varoglutamstat in Early Alzheimer’s Disease
-
Valneva to Present at Upcoming TD Cowen and Van Lanschot Kempen Healthcare Investor Conferences
-
VENTYX ALERT: Bragar Eagel & Squire, P.C. Announces that a Class Action Lawsuit Has Been Filed Against Ventyx Biosciences, Inc. and Encourages Investors to Contact the Firm
-
LIVE NATION ALERT: Bragar Eagel & Squire, P.C. is Investigating Live Nation Entertainment, Inc. on Behalf of Long-Term Stockholders and Encourages Investors to Contact the Firm
-
QUIDELORTHO ALERT: Bragar Eagel & Squire, P.C. is Investigating QuidelOrtho Corporation on Behalf of QuidelOrtho Stockholders and Encourages Investors to Contact the Firm
-
ALIGNMENT ALERT: Bragar Eagel & Squire, P.C. is Investigating Alignment Healthcare, Inc. on Behalf of Alignment Stockholders and Encourages Investors to Contact the Firm
-
LifeWallet Announces a Comprehensive Settlement with 28 Affiliated Property and Casualty Insurers, Benefiting LifeWallet’s Medicare Clients Across the U.S.
-
CHILDREN’S PLACE ALERT: Bragar Eagel & Squire, P.C. Reminds Investors that a Class Action Lawsuit Has Been Filed Against The Children’s Place and Encourages Investors to Contact the Firm
-
Quantexa Strengthens Advisory Board with the Appointment of Boon Hui Khoo
-
Enhancing Omega-3 in diets: Millennial Salmon Project maximizes inclusion of AlgaPrime™ DHA keeping performance in feed production
-
ROSEN, A TRUSTED AND LEADING LAW FIRM, Encourages ADTRAN Holdings, Inc. Investors to Inquire About Securities Class Action Investigation – ADTN
-
Creditor Law Group Defends Thousands of Americans to Resolve Their Debts
-
CyberKart Unveils the Future of Multiplayer Crypto Gaming: A Thrilling Fusion of Racing, Strategy, and Blockchain Technology
-
Ibogaine By David Dardashti Announces Breakthrough Algorithm to Quantify Quantum Electrodynamics
-
BNTX DEADLINE: ROSEN, A TOP RANKED LAW FIRM, Encourages BioNTech SE Investors to Secure Counsel Before Important March 12 Deadline in Securities Class Action – BNTX
-
ROSEN, NATIONAL TRIAL COUNSEL, Encourages Amylyx Pharmaceuticals, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action – AMLX
-
ROSEN, A LEADING NATIONAL FIRM, Encourages Amplitude, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action – AMPL
-
Ibogaine by David Dardashti Creates Innovative Algorithm for Fentanyl Treatment
-
ImpactLife salutes longtime platelet donors on reaching major milestones
-
Ibogaine By David Dardashti Visits Ohio to Explore Economic Benefits
-
ROSEN, LEADING INVESTOR COUNSEL, Encourages QuidelOrtho Corporation Investors to Inquire About Securities Class Action Investigation – QDEL
-
ROSEN, A LEADING LAW FIRM, Encourages Nextdoor Holdings, Inc. f/k/a Khosla Ventures Acquisition Co. II Investors to Secure Counsel Before Important Deadline in Securities Class Action – KIND, KVSB
